New University Enterprise Zone announced
The Milner Therapeutics Institute will form part of a University Enterprise Zone, created through a new government initiative announced today by Universities Minister Chris Skidmore. Research England, part of UK Research and Innovation, today announced 20 new...
Welcome to Pathania group
We are delighted to welcome the group of Manav Pathania (Dept Oncology), who moved into the Milner Institute this month. The Pathania group have a central focus on developing new mouse models for children’s brain tumours, to better understand the diverse genetic basis...
Renewal of Milner Therapeutics Consortium
We are delighted to announce that the Milner Therapeutics Consortium has been renewed until 2024. The Consortium includes 7 pharma companies (Astex, AstraZeneca, Ferring, GlaxoSmithKline, J & J Innovation, Pfizer, Shionogi) who are committed to collaboration and...
Start Codon announced as new world-class life science accelerator
This innovative new accelerator programme will provide significant funding and support for selected start-ups, with office and lab space in the Milner Research Labs.
Cancer Research UK and AstraZeneca launch world class functional genomics centre at the Milner Research Labs
Cancer Research UK and AstraZeneca have announced that they are opening a new centre in the Milner Research Labs in Cambridge, dedicated to realising the full potential of functional genomics in the discovery and development of new drugs for patients with cancer. The...
Milner facilitates strategic partnership between Nemesis and Shionogi
SHIONOGI INVESTS IN NEMESIS TECHNOLOGY Japanese Pharma Company Joins £1.4M Seed Funding Round for Nemesis Bioscience Nemesis Bioscience today announced the completion of a Seed funding round of £1.4M from a syndicate of new investors including Shionogi & Co Ltd,...
The Milner Institute’s new building starts to take shape
Our new building is starting to take shape now, ready for the opening in October. The Milner Therapeutics Institute will have research laboratories within the Capella Building, which is on the Cambridge Biomedical Campus. The laboratories will house research...
LifeArc and Milner Therapeutics Institute announce a new partnership in artificial intelligence and machine learning for target discovery
London and Cambridge, UK 23 January 2018 – LifeArc®, the UK-based medical research charity and the Milner Therapeutics Institute at the University of Cambridge today announced a new partnership to identify and validate new drug targets in immuno-oncology and...